Health-related quality of life and caregiver burden were both significantly correlated with alexithymia in patients with Parkinson disease, with the sub-component “identifying feelings” serving as a key factor.
Health-related quality of life (HR-QOL) and caregiver burden were both significantly correlated with alexithymia in patients with Parkinson disease (PD), with the sub-component “identifying feelings” serving as a key factor.
Over the past 2 decades, alexithymia has become identified as an additional nonmotor symptom in PD. Published in Brain Sciences, researchers explain that this multidimensional psychological construct is based on 4 distinct elements:
Patients with PD (PwP) are notable at-risk populations for alexithymia, with 18% to 23% of PwP meeting the condition’s diagnostic criteria, a figure nearly 2 times greater than the general population. Moreover, those who experience symptoms have been associated with lower satisfaction in life and are more likely to commit suicide.
Researchers noted that the impact of alexithymia on QOL of PwP is poorly understood, with no available data on the effect on caregivers. They examined disease-specific questionnaires to investigate these associations, with 119 PwP and their corresponding caregivers participating in the study.
Participants provided general background information, such as PwP’ disease duration and dedicated time giving care to the patient by caregivers. Caregivers’ HR-QOL was measured by the generic HR-QOL questionnaire short form 36 health survey and PwP HR-QOL was assessed by the Parkinson disease questionnaire 8, with 0 being the worst HR-QOL score and 100 being the best.
PwP further completed the Movement Disorders Society unified Parkinson’s disease rating scale (MDS-UPDRS) part II to evaluate their impairment of daily living, and were examined for alexithymia by the Toronto Alexithymia Scale with 26 items.
After conducting the analyses, HR-QOL of the PwP was found to correlate significantly with alexithymia (P < .001), especially in the sub-components “identifying feelings” (P < .001) and “difficulties describing feelings” (P = .001). Caregiver burden also exhibited a significant correlation with PwP alexithymia (P < .001), with most prominent associations occurring within sub-components “identifying feelings” (P < .008) and “external oriented thinking” (P < .004).
Researchers highlight that these correlations warrant more robust evaluation in assessing the impact of alexithymia due to possible confounders. “Interventions to decrease alexithymia in PwP are needed. These treatments might include psychotherapy and mindfulness-based interventions,” concluded the study authors.
Reference
Klietz M, Schnur T, Drexel SC, et al. Alexithymia is associated with reduced quality of life and increased caregiver burden in Parkinson disease. Brain Sci. Published online June 24, 2020. doi:10.3390/brainsci10060401
Major Study Expands in Hopes to Cure Parkinson Disease
April 19th 2022April is Parkinson’s Disease Awareness month, and on this episode of Managed Care Cast, we take a look at the Parkinson's Progression Markers Initiative (PPMI), a study from the Michael J. Fox Foundation for Parkinson's Research (MJFF). The multicenter, international study aims to end Parkinson disease, which is expected to double worldwide by 2040, to more than 14 million people.
Listen
PD Worsens QOL, Increases Depression in Men More Than Women in the Southeast
February 17th 2023The southeastern areas of the country have worse health outcomes and health-related quality of life (HRQOL) compared with other parts of the United States, with high rates of diabetes, obesity, cancer, and cardiovascular disease.
Read More
An Inside Look at Innovations by MJFF to Assist the Parkinson Community Amid the COVID-19 Pandemic
May 26th 2020On this episode of Managed Care Cast, we speak with Rachel Dolhun, MD, vice president of Medical Communications at The Michael J. Fox Foundation for Parkinson Research, about recent innovations by The Michael J. Fox Foundation to assist patients and families of patients with Parkinson disease in adjusting to this new normal.
Listen